WallStSmart

Lineage, Inc. Common Stock (LINE)vsTPG RE Finance Trust Inc (TRTX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 3949% more annual revenue ($5.36B vs $132.24M). TRTX leads profitability with a 45.6% profit margin vs -1.9%. TRTX earns a higher WallStSmart Score of 48/100 (D+).

LINE

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 6.7Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

TRTX

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 6.5Value: 7.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINEUndervalued (+75.9%)

Margin of Safety

+75.9%

Fair Value

$161.49

Current Price

$35.99

$125.50 discount

UndervaluedFair: $161.49Overvalued
TRTXUndervalued (+23.0%)

Margin of Safety

+23.0%

Fair Value

$11.69

Current Price

$8.46

$3.23 discount

UndervaluedFair: $11.69Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

TRTX3 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Profit MarginProfitability
45.6%10/10

Keeps 46 of every $100 in revenue as profit

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Areas to Watch

LINE4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Revenue GrowthGrowth
-0.2%2/10

Revenue declined 0.2%

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

TRTX4 concerns · Avg: 2.5/10
Market CapQuality
$661.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

Revenue GrowthGrowth
-21.1%2/10

Revenue declined 21.1%

EPS GrowthGrowth
-97.2%2/10

Earnings declined 97.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : TRTX

The strongest argument for TRTX centers on Price/Book, Profit Margin, P/E Ratio. Profitability is solid with margins at 45.6% and operating margin at 17.1%.

Bear Case : LINE

The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.

Bear Case : TRTX

The primary concerns for TRTX are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while TRTX is a declining play — different risk/reward profiles.

LINE is growing revenue faster at -0.2% — sustainability is the question.

LINE generates stronger free cash flow (78M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TRTX scores higher overall (48/100 vs 36/100), backed by strong 45.6% margins. LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.

Visit Website →

TPG RE Finance Trust Inc

REAL ESTATE · REIT - MORTGAGE · USA

TPG RE Finance Trust, Inc., a commercial real estate finance company, originates, acquires and manages commercial mortgage loans and other commercial real estate-related debt instruments in North America. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?